Contaminated chemo drugs, the FDA, and chemical warfare against the…

Chemo drugs are highly poisonous to begin with. But suppose, on top of that, they’re contaminated and tainted?
Welcome to the FDA: the handmaiden to Big Pharma; the promoter of destructive medicines; the opponent of natural health; the agency that should have been disbanded and fumigated decades ago. Corruption Central.
In today’s episode, the Agency has issued a slap on the wrist to Fresenius, a major provider of health care in Europe, with two dozen drug-manufacturing facilities around the world.
Bloomberg reports: ‘U. S. regulators warned Fresenius SE after the company’s Indian plant that makes cancer-drug ingredients for the U. S. market aborted hundreds of drug-quality tests because they seemed like they were going to fail due to impurities.’
‘When workers at the plant found potential tainted products, they halted the tests and said human or machine errors were to blame instead, according to a Food and Drug Administration warning letter dated Dec. 4 that cited 248 aborted checks at the West Bengal facility.’

This post was published at Jon Rappoport on December 29, 2017.

Contaminated chemo drugs, the FDA, and chemical warfare against the public

Chemo drugs are highly poisonous to begin with. But suppose, on top of that, they’re contaminated and tainted?
Welcome to the FDA: the handmaiden to Big Pharma; the promoter of destructive medicines; the opponent of natural health; the agency that should have been disbanded and fumigated decades ago. Corruption Central.
In today’s episode, the Agency has issued a slap on the wrist to Fresenius, a major provider of health care in Europe, with two dozen drug-manufacturing facilities around the world.
Bloomberg reports: ‘U. S. regulators warned Fresenius SE after the company’s Indian plant that makes cancer-drug ingredients for the U. S. market aborted hundreds of drug-quality tests because they seemed like they were going to fail due to impurities.’
‘When workers at the plant found potential tainted products, they halted the tests and said human or machine errors were to blame instead, according to a Food and Drug Administration warning letter dated Dec. 4 that cited 248 aborted checks at the West Bengal facility.’
The FDA’s warning basically instructed Fresenius to do better. Re-examine all their manufacturing and testing practices. Hire an outside consultant.
That’s comforting, isn’t it? With contaminated chemo drugs floating around the world, the FDA says nothing about ferreting out these medicines – and here is the capper from the Bloomberg article:
‘The agency also warned that if the company doesn’t correct the issues raised in the letter, FDA workers could refuse products made at the facility admission into the U. S.’

This post was published at Jon Rappoport on Dec 29, 2017.

Global vaccine cartel wreaks destruction: the evidence

Massive vaccine damage, hidden.
Put these two public-health agency statements up against each other:
DON’T GIVE THIS VACCINE TO PEOPLE WHOSE IMMUNE SYSTEMS ARE WEAK, BECAUSE DIRE CONSEQUENCES WOULD FOLLOW.
WE GAVE THIS VACCINE TO 100 MILLION PEOPLE, MILLIONS OF WHOM HAD WEAK IMMUNE SYSTEMS, AND IT WAS A GLORIOUS SUCCESS, ONE OF THE GREATEST ACHIEVEMENTS IN THE HISTORY OF MODERN MEDICINE.
Doesn’t add up, does it? Across a population of 100 million people, widespread harm and death would have occurred.
Read on, and follow the inexorable logic.
The FDA released a statement (8/28/17), about its crackdown on a California company pushing an unapproved treatment for cancer patients: stem cells mixed with a smallpox vaccine.
But that’s not the big story. The big story is buried in the FDA press release. Here is the Agency’s statement:
‘Serious health problems, including those that are life-threatening, can also occur in…people who…have problems with their heart or immune system if they become infected with the [smallpox] vaccine virus, either by being vaccinated or by being in close contact with a person who was vaccinated.’

This post was published at Jon Rappoport on Dec 6, 2017.

Amazon Announces “AWS Secret” Service For The CIA, US Intelligence

Shortly after Wired first profiled the NSA’s new super spycenter in Bluffdale, Utah (one year before Snowden confirmed that much of the agency’s activity involved spying on US citizens and soon to be presidents), speculation emerged as to how much data storage capacity this brand new US spy hub would have. According to a then-estimate by Forbes, the storage capacity at the Bluffdale facility was between 3 and 12 exabytes ( 1 exabyte is 1 billion gigabytes) based on analysis of unclassified blueprints, although some had vastly greater estimates ranging from yottabytes (in Wired) to 5 zettabytes (on NPR), a.k.a. words that most probably can’t pronounce but translate to ‘a lot.‘
And, in retrospect, it appears to not have been enough, because on Monday, Amazon Web Services announced it was now offering a commercial cloud service to the US Intelligence Community (i.e. spies on both foreign targets and US presidential campaigns) called, directly enough “Secret Region” that can operate workloads up to the Secret U. S. security classification level.
‘Today we mark an important milestone as we launch the AWS Secret Region,’ said Teresa Carlson, Vice President, Amazon Web Services Worldwide Public Sector. ‘AWS now provides the U. S. Intelligence Community a commercial cloud capability across all classification levels: Unclassified, Sensitive, Secret, and Top Secret. The U. S. Intelligence Community can now execute their missions with a common set of tools, a constant flow of the latest technology and the flexibility to rapidly scale with the mission. The AWS Top Secret Region was launched three years ago as the first air-gapped commercial cloud and customers across the U. S. Intelligence Community have made it a resounding success. Ultimately, this capability allows more agency collaboration, helps get critical information to decision makers faster, and enables an increase in our Nation’s Security.’

This post was published at Zero Hedge on Nov 20, 2017.

3 PROVEN THINGS SCHOOLS CAN DO TO CURB THE ADHD EPIDEMIC WITHOUT PRESCRIBING DRUGS TO KIDS

We really just don’t know what the long-term, generational effects of such widespread use of ADHD medications will be on our society and the individuals who’ve been taking these meds their whole lives.
There have never been long-term studies because the medications have not been around for very long, yet the FDA and Big Pharma are perfectly comfortable pushing these pills onto the public.
The truth is that they do not want people to be healthy and free of dependency on pharmaceuticals, they want customers and cash flow and don’t care if children as young as one year old are being put on these drugs.
If these institutions actually cared for our well-being and welfare, they would undoubtedly strive to put as few people as possible on these meds. They would especially refuse to give these to children without thoroughly examining all options and possibilities before introducing prescription speed to alter the behavior of kids who don’t seem to adapt well to the modern schooling environment.
If they really cared for our welfare, they would demand that before any child is given these medications they were given the opportunity to try out and explore natural, non-chemical alternatives.
We have plenty of evidence suggesting that common sense alternatives work well to positively influence the behavior of school children, and here are three that we know work well.

This post was published at The Daily Sheeple on NOVEMBER 18, 2017.

FDA Approves New Digital Sensor To Ensure ‘Patients With Mental Health Issues’ Take Their Meds

The Food and Drug Administration has just approved a new pill with a digital sensor in it. It will ‘ensure’ that patients who suffer from mental health issues take their medicine when they are told. But privacy concerns have not gone unnoticed.
Regulators in the United States have approved the first bill that can be digitally tracked as it makes its way through the human body. The Abilify MyCite aripiprazole tablets used for treating schizophrenia and manic episodes have an ingestible sensor embedded inside them that records that the medication has been taken. A patch worn by the patient transmits this information to their smartphone.
But many are raising the red flag that this could simply be another form of medical ‘big brother.’ You may no longer have the right to refuse medications in the very near future.

This post was published at shtfplan on November 14th, 2017.

Jon Rappoport on Coast to Coast AM with George Noory: the OPIOID CRISIS

Help spread the word. I’ll be exposing and explaining the crisis and its extreme danger to populations all over the world.
For now: Federal agents arrest drug-company founder for opioid racketeering
Federal agents have arrested John Kapoor, the founder of drug-company Insys, for opioid racketeering.
FBI spokesman Harold Shaw said the arrest marks ‘an important step in holding pharmaceutical executives responsible for their part in the opioid crisis.’
Among the charges against Kapoor: promoting off-label uses for the company’s painkiller, Subsys, and bribing physicians to write prescriptions.
Essentially, the charge is: ‘you’re a drug trafficker.’
Doctors can prescribe drugs for conditions beyond those listed in the FDA’s specific approval. That’s what ‘off-label use’ means. But the drugs’ manufacturers can’t actively promote or pay doctors to write off-label prescriptions. That’s a crime.

This post was published at Jon Rappoport on October 31, 2017.

Reminder: murder at the FDA

File this one under: ‘studiously ignored by major media.’
I first posted this story in August of 2012. It was based on a Truthout interview of a man who did drug reviews for the FDA. He examined applications to approve new medical drugs.
Pharmaceutical companies must have their new drugs certified as safe and effective before they can enter the market, before doctors can prescribe them. The FDA does this certification. Thumbs up or thumbs down.
Here’s the story:
In a stunning interview with Truthout’s Martha Rosenberg, former FDA drug reviewer, Ronald Kavanagh, exposes the FDA as a relentless criminal mafia protecting its client, Big Pharma, with a host of mob strategies.
Kavanagh: ‘…widespread racketeering, including witness tampering and witness retaliation.’

This post was published at Jon Rappoport on September 22, 2017.

When I ran for Congress: insights

When I ran for Congress: insights
‘I met with one nutritional-supplement-company president, a self-involved oaf who bragged about his expensive tastes, his vacations, his large house. His main advice (he didn’t back my campaign with a donation) was to see his tailor and have him make me a high-priced suit.’
By Jon Rappoport
Ultimately, I believed vote fraud occurred in my 1994 run for a seat in the US Congress, from the 29th District in Los Angeles. I’ve written and spoken about that elsewhere.
This article is about something else.
I was running at the height of the so-called Health Freedom movement in America. My primary issue was the right of every person to manage his/her own health. The right to have access to the full range of nutritional supplements (under attack by the FDA). The right to consult alternative health practitioners (the FDA was attacking those practitioners). The right to know the full truth about toxic medical drugs. The right to refuse medical treatments. The right to have the FDA prosecuted for criminal collusion with drug companies.
The Health Freedom movement spawned more letters to Congress than any issue in the history of America. Several nutritional companies were backing the movement with money.

This post was published at Jon Rappoport on September 19, 2017.

Seattle Seahawks Flee America for Medical Treatment

Baseball may still identify as America’s pastime, but every year consumers prove that football is the country’s true love. In fact, the intertwining of national identity and the NFL can often be troublesome, such as when the Pentagon pays the league to promote the military – or the large subsidies governments grant to help billionaires pay for new stadiums. Yet increasingly America’s best athletes in America’s favorite sport have to flee the country to get medical treatment, because of an opponent more dangerous than Ndamukong Suh: the Food and Drug Administration.
On Monday, Seattle Seahawks head coach Pete Carroll informed the media that five players on the team had left the country in order to receive Regenokine therapy. With linebacker KJ Wright just returning to the team after his own therapeutic trip, this means that over 10% of the team’s roster has had to go overseas to get ready for the 2017 season.
The treatment, which includes injecting the patient with a serum derived from their own blood, has become popular among athletes suffering from joint pain. In 2012, Kobe Bryant famously flew to Germany for the treatment, which he credited with allowing him to continue playing basketball. In fact, Dr. Peter Wehling claims his treatment has a 90% success rate, which has been supported by published studies.
Unfortunately for America’s athletes, Regenokine has still not been approved by the FDA. This means that not only is it more expensive and difficult for athletes to receive the treatment’s benefits – but renders it almost impossible for the millions of average Americans suffering from chronic pain.

This post was published at Ludwig von Mises Institute on August 31, 2017.

Exclusive: mind-boggling FDA confession about the smallpox vaccine

The FDA has just released a statement (8/28) about its crackdown on a California company pushing an unapproved treatment for cancer patients: stem cells mixed with a smallpox vaccine.
But that’s not the big story. The big story is buried in the FDA press release. Here is the Agency’s statement:
‘Serious health problems, including those that are life-threatening, can also occur in…people who…have problems with their heart or immune system if they become infected with the [smallpox] vaccine virus, either by being vaccinated or by being in close contact with a person who was vaccinated.’
The FDA states that those with certain prior health conditions who pick up the smallpox virus, as a result of vaccination, are at exceptionally high risk. AMONG THOSE PRIOR HEALTH CONDITIONS IS: ‘IMMUNE SYSTEM PROBLEMS.’
That simply means weak and compromised immune systems.
And yet…during the years 1966-1980, a massive smallpox eradication campaign was carried out in Africa, under the auspices of the World Health Organization. Roughly 100 million doses of the smallpox vaccine were given to Africans, MANY OF WHOM ALREADY HAD COMPROMISED IMMUNE SYSTEMS.

This post was published at Jon Rappoport on August 30, 2017.

NESTL FACES LAWSUIT FOR MISLABELING COMMON GROUND WATER AS SPRING WATER

A group of concerned citizens has brought a 325-page class action lawsuit against Nestl Waters North America, the company that owns Poland Spring, alleging that the Maine business has long deceived their customers by mislabeling common groundwater as ‘spring water,’ Courthouse News reported.
The lawsuit was filed in a Connecticut federal court on Tuesday accusing Nestl Waters North America Inc. of a ‘colossal fraud perpetrated against American consumers.’
The civil suit was brought by 11 people who are seeking millions of dollars in damages seeking whether the sources of Poland Spring’s water meets the Food and Drug Administration’s (FDA) definition of a spring.
The suit alleges that the Poland Springs’ wells in Poland, Maine, Hollis, Fryeburg, Denmark, Dallas Plantation, Pierce Pond Township and Kingfield have never been scientifically proven to be connected to a spring and draw in surface water, which cannot legally be called spring water.

This post was published at The Daily Sheeple on AUGUST 22, 2017.

Vaccine disasters governments want you to forget

Parents who question vaccines are crazy? Really? Parents who claim to discover vaccine-dangers are crazy? Really?
Official history is a curious thing. Whole sections of fact disappear from the record.
When I was researching my first book, AIDS INC., in 1987-88, I explored various forms of immune-system suppression, in order to show that HIV was not the real story.
I looked into vaccines, for example. Here is an excerpt from AIDS INC. Keep in mind that my research, at the time, ended in 1988. This excerpt reports on vaccines disasters and statements about vaccines made by several authors.
It is forgotten history:
‘… Based on the only U. S. findings on adverse DPT [diphtheria-pertussis-tetanus vaccine] reactions, an FDA-financed study at the University of California, Los Angeles, one out of every 350 children will have a convulsion; one in 180 children will experience high-pitched screaming [can indicate brain damage]; and one in 66 will have a fever of 105 degrees or more.’ (Jennifer Hyman, Democrat and Chronicle, Rochester, New York, special supplement on DPT, dated April, 1987.)

This post was published at Jon Rappoport on August 18, 2017.

Why Some Pharmaceuticals Are So Expensive

Enter ‘outrageous drug prices’ into Google and you will receive plenty of examples. As reported here, Marathon Pharmaceuticals planned to charge $89,000 per year for its Emflaza brand of the corticosteroid deflazacort. Deflazacort was introduced in 1969 and is available outside the U. S. for less than $2 per tablet. US patients with muscular dystrophy have been obtaining the drug for around $1,500 per year from foreign sources.
This pricing behavior cannot occur in a free market. In a free or unhampered market, if Marathon tried to charge $89,000 for a year’s supply of deflazacort, they would realize zero sales. There are at least 169 generic manufacturers of at least 300 brands of deflazacort. One or more competitors of Marathon would gladly supply the drug for a lower price. In a situation with robust competition, the price will move toward the minimal cost of production plus transport over time. Marathon can make its pricing decision, and expect to realize sales, because a government agency gave Marathon monopoly privilege to sell deflazacort in the United States.
The debate over whether drug patents are beneficial to society is outside the scope of this discussion. Proponents of monopoly privilege for pharmaceuticals must admit, however, that the monopoly privilege enables the outrageous prices. In the case of Emflaza, Marathon did not develop a new drug. Deflazacort has been in use since 1969. The FDA awarded monopoly privilege to Marathon Pharmaceuticals for acquiring old clinical trial data and performing some additional analyses.

This post was published at Ludwig von Mises Institute on August 13, 2017.

Guide to paying a small fine and making billions

The key factor is: be a drug company.
In this case, Celgene. Their drugs are Thalomid and Revlimid. They are approved for multiple myeloma, one type of cancer.
Here’s the thing. Doctors can decide to prescribe drugs for uses which are not approved by the FDA, but the manufacturers can’t promote those ‘off-label’ uses to doctors. That’s illegal.
A long-running suit against Celgene, launched by Beverly Brown, who used to be the company’s sales manager, contends that:
Celgene trained its sales team to promote off-label uses to doctors;
Celgene sales people intentionally lied about studies, claiming the studies showed the off-label uses were beneficial to patients;
And the company omitted vital warnings about the drugs’ uses from the drugs’ labels.
Back in 2014, the judge in the case, George King, slammed Celgene for trying to convince him to dismiss the case. King pointed out that the plaintiff, Beverly Brown, appeared to have direct knowledge of the scam, because company higher-ups laid out the details to her.
Finally, now, the lawsuit has been settled. Celgene will pay out $280 million.
But wait. Revlimid, one of the two Celgene drugs named in the suit, garnered a whopping $5 billion in sales, in 2015. FiercePharma, a website dedicated to industry news, predicts the drug will rake in $15 billion in 2022.

This post was published at Jon Rappoport on July 30, 2017.

Tobacco Stocks Are Getting Smoked, Here’s Why…

U. S. tobacco stocks are getting smoked this morning (led by an 12% crash in British American Tobacco and Philip Morris) after an FDA statement said it plans to purse lowering nicotine in cigarettes to non-addictive levels.
Bloomberg reports,
The U. S. Food and Drug Administration will work to cut the amount of nicotine in cigarettes to nonaddictive levels, with the goal of preventing thousands of tobacco-related deaths a year. The surprise move sent shares of cigarette stocks plummeting. While the FDA’s effort is likely to be heavily opposed by cigarette makers such as Altria Group Inc. and British American Tobacco Plc, the move by the agency is aimed at one of the U. S.’s biggest causes of preventable illness that the FDA says is responsible for 480,000 deaths a year as well as hundreds of billions of dollars in medical costs and lost productivity.
‘The overwhelming amount of death and disease attributable to tobacco is caused by addiction to cigarettes — the only legal consumer product that, when used as intended, will kill half of all long-term users,’ FDA Commissioner Scott Gottlieb said in a statement announcing the move. ‘Unless we change course, 5.6 million young people alive today will die prematurely later in life from tobacco use.’
The move threatens to deal a crushing blow to tobacco companies, which are already coping with shrinking cigarette volumes in the U. S. It also puts pressure on the industry to speed so-called reduced-risk products to market.

This post was published at Zero Hedge on Jul 28, 2017.

Is Trump’s investigation of vaccine-dangers dead?

Trump has made two key appointments in the area of childhood vaccination. The first was Scott Gottlieb, the director of the FDA. What does Gottlieb have to say?
From fiercepharma.com: ‘…antivaccine activists were disappointed with Trump’s appointment for FDA head, Scott Gottlieb, who has said any theories of a link between vaccines and autism have been ‘thoroughly debunked’.’
Trump’s second key appointment has now been revealed. Dr. Brenda Fitzgerald takes over as the head of the CDC.
Georgia Department of Public Health: ”Immunizations are the best way to protect infants and children from childhood diseases, like whooping cough and measles that can be life-threatening at young ages’,’ said Brenda Fitzgerald, M. D., commissioner of the Georgia Department of Public Health [before her appointment to lead the CDC]. ‘It is critical for parents to talk to their child’s doctor to ensure they are up-to-date on immunizations, because no child should have to suffer a vaccine-preventable illness’.’
In 2014, Dr. Fitzgerald wrote an op-ed in the Atlanta Journal-Constitution: ‘I’ve heard all the arguments against vaccination. All have been debunked…’

This post was published at Jon Rappoport on July 7, 2017.

Amish Man Sentenced To Six Years In Prison For Not Seeking FDA Approval

Kentucky – ‘I am not a creation of state/government, as such I am not within its jurisdiction.’
Those words were written by Samuel Girod in a document filed in a Kentucky federal court in June. Girod is an Amish farmer who was convicted in March of selling herbal health products that, as reported by the Lexington Herald-Leader on Friday, ‘were not adequately labeled as required by federal law.’
According to the government, the Amish man broke the law by growing, processing, and bringing to market his own herbal supplements without FDA approval. US News reported that Girod manufactured salves and skin treatments, one of which the FDA claims could be harmful to the skin. He also claimed one extract could help cure cancer, which the FDA disputed. In 2013, Giron ignored orders from the FDA to stop selling his products.
Nevertheless, he rejected the notion that he deserved six years in prison for being at odds with the federal agency (which, itself, approves numerous dangerous drugs).

This post was published at The Daily Sheeple on July 3, 2017.

Shut down the FDA, start over

Vera Sharav, at ahrp.org, has posted a piece about an investigation headed by NYU Professor Charles Seife.
Seife and his students probed the work of the FDA, the federal agency tasked with approving medical drugs for public use.
Sharav: ‘FDA documents obtained under the Freedom of Information Act, revealed that the FDA has been concealing from the medical community and the public serious research misconduct; including fraud, deception, avoidable risks for human subjects – even deaths – that occurred in clinical trials [of medical drugs].’
Professor Seife (from his article at Slate magazine): ‘Reading the FDA’s inspection files feels almost like watching a highlights reel from a Scientists Gone Wild video. It’s a seemingly endless stream of lurid vignettes – Faked X-ray reports. Forged retinal scans. Phony lab tests. Secretly amputated limbs. All done in the name of science when researchers thought that nobody was watching.’
‘That misconduct happens isn’t shocking. What is: When the FDA finds scientific fraud or misconduct, the agency doesn’t notify the public, the medical establishment, or even the scientific community that the results of a medical experiment are not to be trusted. On the contrary. For more than a decade, the FDA has shown a pattern of burying the details of misconduct. As a result, nobody ever finds out which data is bogus, which experiments are tainted, and which drugs might be on the market under false pretenses.’

This post was published at Jon Rappoport on Apr 19, 2017.

Here we go again: FDA Commissioner in pocket of Big Pharma

The excellent medical reporter, Martha Rosenberg, has written a piece at Salon: ‘The FDA Now Officially Belongs to Big Pharma.’ Here are a few highlights:
It is hard to believe only four senators opposed the confirmation of [the new FDA Commissioner]…[he] received money from 23 drug companies including the giants like Johnson & Johnson, Lilly, Merck, Schering Plough and GSK…’
‘[He] also lists financial links to Gambro, Regeneron, Gilead, AstraZeneca, Roche and other companies and equity positions in four medical companies. Gilead is the maker of the $1000-a-pill hepatitis C drug AlterNet recently wrote about. This is FDA commissioner material?’
Oh, wait. I’m sorry.
Gee whiz. How could I have made that mistake?
I must have been asleep. Wow. I apologize. Martha Rosenberg published that Salon article in February of 2016, and she was talking about Robert Califf, who had just been confirmed as the new FDA Commissioner.
Califf was nominated by Obama, not Trump. Oops.

This post was published at Jon Rappoport on Apr 17, 2017.